Navigation Links
Studying bed bug actions for new management tactics
Date:2/11/2013

This press release is available in Spanish.

Learning more about the behavior of bed bugs is one approach being used by U.S. Department of Agriculture (USDA) scientists to identify compounds to help control these pests.

The resurgence of bed bugs over the last decade has caused problems in major U.S. cities where they infest homes, apartments, hotels, shelters and even places of work. The small, blood-feeding insects are not known to transmit diseases, but they can cause severe reactions in people who are allergic to them. Bed bugs usually go unnoticed until their numbers increase significantly, and getting rid of them can be costly.

Entomologist Mark Feldlaufer and chemist Kamlesh Chauhan at the Agricultural Research Service (ARS) Henry A. Wallace Beltsville Agricultural Research Center (BARC) in Beltsville, Md., have identified two new alarm pheromones4-oxo-hexenal and 4-oxo-octenalin immature bed bugs. The releasing of alarm pheromones, which are defensive compounds, causes aggregated bed bugs to scatter.

Scientists collected cast skins that retain chemicals from the bed bug's scent glands and then used gas chromatography and mass spectrometry technology to analyze and identify compounds. Swedish researchers subsequently identified the same compounds from a related species, the tropical bed bug, demonstrating that the compounds are biologically active.

This indicates that alarm pheromones may have implications in bed bug management, according to Feldlaufer, who works at BARC's Invasive Insect Biocontrol and Behavior Laboratory. By causing insects to disperse, the likelihood of bed bugs coming into contact with a control agent increases.

ARS and University of Nevada-Reno scientists also identified 17 compounds in the bed bug's outer protective layer of skin, a discovery they believe may play an important role in bed bug aggregation behavior.


'/>"/>

Contact: Sandra Avant
Sandra.avant@ars.usda.gov
301-504-1627
United States Department of Agriculture - Research, Education and Economics
Source:Eurekalert

Related biology news :

1. Genetic research develops tools for studying diseases, improving regenerative treatment
2. Studying sex differences in autism focus of $15 million NIH award to Yale center
3. U of M to lead international virtual institute studying climatic and human effects on Earth
4. Bioengineer studying how to send drugs to lungs through nanotechnology
5. Scientists study the catalytic reactions used by plants to split oxygen from water
6. Drug interactions wont exclude HCV transplant or HIV co-infected patients from treatment
7. La Jolla Institute discovery could lead to new way to screen drugs for adverse reactions
8. How bacteria change movement direction in response to oxygen: Molecular interactions unravelled
9. Researchers describe new molecular interactions behind the inhibition of TGF beta-signaling
10. Einstein researcher receives $10.8 million grant to study toxic blood reactions caused by hemoglobin
11. Rice uses light to remotely trigger biochemical reactions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/7/2017)... 7, 2017   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that the ... innovative, highly flexible and award winning eClinical solution, is ... iMedNet is a proven Software-as-a-Service (SaaS) clinical research ... (EDC), but also delivers an entire suite of eClinical ...
(Date:2/6/2017)... Feb. 6, 2017 According to Acuity ... driving border authorities to continue to embrace biometric ... are 2143 Automated Border Control (ABC) eGates and ... at more than 163 ports of entry across ... 2016 achieving a combined CAGR of 37%. APC ...
(Date:2/2/2017)... 2, 2017   TapImmune, Inc. (NASDAQ: ... specializing in the development of innovative peptide and ... cancer and metastatic disease, announced today it has ... of a second clinical lot of TPIV 200, ... alpha. The manufactured vaccine product will be used ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... clinical-stage oncology and dermatology biopharmaceutical company, today is ... in its previously announced rights offering of up ... common stock and Series C Convertible Preferred Stock ... As previously announced, the rights ...
(Date:2/24/2017)... Feb. 24, 2017 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory testing, hematopoietic ... announced its unaudited financial results for the third quarter ... December 31, 2016. Third Quarter of Fiscal ... quarter of fiscal 2017 increased by 18.6% to RMB200.9 ...
(Date:2/24/2017)... , Feb. 24, 2017  OncoSec Medical Incorporated ... immunotherapies, will host a Key Opinion Leader event to ... an oral and poster presentation at the upcoming 2017 ... The KOL event will be held in-person and via ... EST / 9:00 AM PST at the Lotte New ...
(Date:2/23/2017)... 2017 /PRNewswire/ - The Fight Against Cancer Innovation Trust ... are pleased to report that Fusion Pharmaceuticals Inc. (Fusion) ... & Johnson Innovation – JJDC, Inc. (JJDC) as the ... TPG Biotechnology Partners, and Genesys Capital, as well as ... ...
Breaking Biology Technology: